Pfizer Investigational Site — Staten Island, New York

Pfizer Investigational Site is a clinical research site located in Staten Island, New York, United States 10304.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Pfizer Investigational Site has participated in 16 clinical trials.

Therapeutic areas: Schizophrenia, Alzheimer Disease, Bipolar Disorder.

Sponsors: Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Wyeth is now a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pfizer Investigational Site?

Pfizer Investigational Site has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pfizer Investigational Site conducted?

Pfizer Investigational Site has 16 clinical trials on record. Their work covers Schizophrenia, Alzheimer Disease, Bipolar Disorder.

Is Pfizer Investigational Site accredited by Crixeo Health?

Yes — Pfizer Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Pfizer Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.